U.S. markets closed

Evelo Biosciences, Inc. (EVLO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
11.560.00 (0.00%)
At close: 4:00PM EDT
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Total Revenue
0
0
0
0
-
Operating Expense
91,886
91,886
86,357
58,103
27,531
Operating Income
-91,886
-91,886
-86,357
-58,103
-27,531
Net Non Operating Interest Income Expense
-2,109
-2,109
1,049
1,563
-215
Other Income Expense
738
738
26
-406
-301
Pretax Income
-93,257
-93,257
-85,282
-56,946
-28,047
Tax Provision
409
409
190
-
-
Net Income Common Stockholders
-93,666
-93,666
-85,472
-60,883
-34,132
Diluted NI Available to Com Stockholders
-93,666
-93,666
-85,472
-60,883
-34,132
Basic EPS
-
-
-2.67
-2.78
-1.48
Diluted EPS
-
-
-2.67
-2.78
-1.48
Basic Average Shares
-
-
32,032
21,871
18,808
Diluted Average Shares
-
-
32,032
21,871
18,808
Total Operating Income as Reported
-91,886
-91,886
-86,357
-58,103
-27,531
Total Expenses
91,886
91,886
86,357
58,103
27,531
Net Income from Continuing & Discontinued Operation
-93,666
-93,666
-85,472
-56,946
-28,047
Normalized Income
-93,666
-93,666
-85,472
-56,946
-28,047
Net Interest Income
-2,109
-2,109
1,049
1,563
-215
EBIT
-91,886
-91,886
-86,357
-58,103
-27,531
EBITDA
-89,860
-
-
-
-
Reconciled Depreciation
2,026
2,026
1,764
1,935
834
Net Income from Continuing Operation Net Minority Interest
-93,666
-93,666
-85,472
-56,946
-28,047
Normalized EBITDA
-89,860
-89,860
-84,593
-56,168
-26,697
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0